According to a recent study, patients with moderate or severe COVID-19 mainly developed mild-to-severe pulmonary fibrosis, and the severe lung inflammation (IL-6 levels in the acute stage) has been associated with more extensive and severe residual pulmonary fibrosis [50]. The gene discussed is IL6; the disease is COVID-19.